Literature DB >> 6453413

Current status of nitrosoureas under development in Japan.

M Ogawa, S Fujimoto.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6453413     DOI： 10.1007/978-3-642-81565-2_10

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  3 in total

1.  CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.

Authors:  K Schieweck; J Stanek; P M Kanter; K H Schmidt-Ruppin; M Müller; A Matter
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.

Authors:  S Fujimoto; Y Wang; M Ogawa
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.

Authors:  S Fujimoto; M Ogawa
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.